Back
KalVista Pharmaceuticals Vs. Xtant Medical Holdings Industry Stock Comparison
Buy
56
KALV
KalVista Pharmaceuticals
Last Price:
11.91
Seasonality Move:
3.19%
Sell
48
XTNT
Xtant Medical Holdings
Last Price:
0.73
Seasonality Move:
6.74%
Buy
56
KalVista Pharmaceuticals (KALV)
is a Buy
Is KalVista Pharmaceuticals a Buy, Sell or Hold?
- The current KalVista Pharmaceuticals [KALV] share price is $11.92. The Score for KALV is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- KALV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Xtant Medical Holdings (XTNT)
is a Sell
Is Xtant Medical Holdings a Buy, Sell or Hold?
- The current Xtant Medical Holdings [XTNT] share price is $0.72. The Score for XTNT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- XTNT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KALV Stock Price Chart
What is KalVista Pharmaceuticals's stock price today?
-
The KalVista Pharmaceuticals share price today is $11.92
The current trend is relatively stagnant and KALV is experiencing slight selling pressure.
XTNT Stock Price Chart
What is Xtant Medical Holdings's stock price today?
-
The Xtant Medical Holdings share price today is $0.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTNT is experiencing slight selling pressure.
KALV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 50.6 | Buy |
| Chaikin Money Flow: | -14677 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.15 - 12.25) | Buy |
| Bollinger Bands (100): | (11.35 - 14.03) | Sell |
XTNT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 33.3 | Sell |
| Chaikin Money Flow: | -19144 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.78 - 0.9) | Sell |
| Bollinger Bands (100): | (0.89 - 1.15) | Sell |
KALV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.09 | Sell |
| 20-day SMA: | 11.71 | Buy |
| 50-day SMA: | 11.79 | Buy |
| 200-day SMA: | 11.12 | Buy |
| 8-day EMA: | 12.04 | Sell |
| 20-day EMA: | 11.9 | Buy |
| 50-day EMA: | 11.98 | Sell |
| 200-day EMA: | 11.33 | Buy |
XTNT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.78 | Sell |
| 20-day SMA: | 0.84 | Sell |
| 50-day SMA: | 0.94 | Sell |
| 200-day SMA: | 1.1 | Sell |
| 8-day EMA: | 0.77 | Sell |
| 20-day EMA: | 0.83 | Sell |
| 50-day EMA: | 0.91 | Sell |
| 200-day EMA: | 1 | Sell |
KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.62 per share.
Xtant Medical Holdings Earnings Growth & XTNT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.07 per share.
KalVista Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xtant Medical Holdings Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||